Ignite Creation Date:
2025-12-25 @ 4:25 AM
Ignite Modification Date:
2025-12-26 @ 3:29 AM
Study NCT ID:
NCT01231620
Status:
COMPLETED
Last Update Posted:
2018-10-15
First Post:
2010-10-28
Is NOT Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
A Study of Intravenous Zanamivir Versus Oral Oseltamivir in Adults and Adolescents Hospitalized With Influenza
Sponsor:
GlaxoSmithKline
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Influenza, Human | View |
Keywords:
Keywords
| Keyword Brief | Keyword Text | View |
|---|---|---|
| None | Seasonal Influenza | View |
| None | Pandemic | View |
| None | Orthomyxoviridae Infections | View |
| None | Influenza | View |
| None | Influenza A Virus, H1N1 Subtype | View |
| None | Enzyme Inhibitors | View |
| None | Influenza, seasonal | View |
| None | Respiratory Tract Diseases | View |
| None | Zanamivir | View |
| None | Pharmacologic Actions | View |
| None | Antiviral Agents | View |
| None | Anti-Infective Agents | View |
| None | H1N1 | View |
| None | Neuraminidase inhibitor | View |
| None | Influenza B virus | View |